In contrast, CD19 is considered a rarely and infrequently expressed target antigen in other hematologic malignancies, including multiple myeloma, which is characterized by clonal proliferation of plasma cells that produce aberrant immunoglobulin6,7. Here, CD19 is linked to AL amyloidosis.